Literature DB >> 9101672

Management of involuntary childlessness.

W Himmel1, E Ittner, M M Kochen, H W Michelmann, B Hinney, M Reuter, M Kallerhoff, R H Ringert.   

Abstract

Any definition of involuntary childlessness has to consider the difference between sterility and subfertility. As the latter affects about 20-30% of all couples at least once in their lives, general practitioners (GPs) may be the first to be confronted with this problem. This review presents the most relevant diagnostic and therapeutic options in cases of female or male infertility, and discusses the new assisted reproductive technologies (such as insemination, in vitro fertilization, gamete transfer and intracytoplasmatic sperm injection) so that GPs may adequately inform their patients about these procedures and their risks and outcomes. Although controversial, involuntary childlessness and its clinical treatment seem to have a strong psychological impact on a couple's social, emotional and sexual life. Being available for discussion with childless couples and offering ongoing support may be the most important role for the GP in this context.

Entities:  

Mesh:

Year:  1997        PMID: 9101672      PMCID: PMC1312893     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  113 in total

1.  Ambiguous responsibility in the doctor-patient relationship: the case of infertility.

Authors:  G Becker; R D Nachtigall
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

2.  Experience with 425 subfertile male patients.

Authors:  S H Greenberg; L I Lipshultz; A J Wein
Journal:  J Urol       Date:  1978-04       Impact factor: 7.450

3.  The psychological component of infertility.

Authors:  P P Mahlstedt
Journal:  Fertil Steril       Date:  1985-03       Impact factor: 7.329

4.  Psychogenic factors in some genetic and non-genetic forms of infertility.

Authors:  J R Singh; J S Neki
Journal:  Int J Gynaecol Obstet       Date:  1982-04       Impact factor: 3.561

5.  Letters to Dr Frankenstein? Ethics and the new reproductive technologies.

Authors:  H ten Have
Journal:  Soc Sci Med       Date:  1995-01       Impact factor: 4.634

6.  Magnified surgery for epididymovasostomy.

Authors:  L Dubin; R D Amelar
Journal:  Urology       Date:  1984-05       Impact factor: 2.649

7.  A controlled study of human chorionic gonadotrophin induced ovulation versus urinary luteinizing hormone surge for timing of intrauterine insemination.

Authors:  A R Martinez; R E Bernadus; F J Voorhorst; J P Vermeiden; J Schoemaker
Journal:  Hum Reprod       Date:  1991-10       Impact factor: 6.918

8.  Infertility--epidemiology and referral practice.

Authors:  A Templeton; C Fraser; B Thompson
Journal:  Hum Reprod       Date:  1991-11       Impact factor: 6.918

9.  Intracytoplasmic sperm injection facilitates fertilization even in the most severe forms of male infertility: pregnancy outcome correlates with maternal age and number of eggs available.

Authors:  R J Sherins; L P Thorsell; A Dorfmann; L Dennison-Lagos; L P Calvo; L Krysa; C B Coulam; J D Schulman
Journal:  Fertil Steril       Date:  1995-08       Impact factor: 7.329

10.  Tubal catheterization for intrafallopian insemination and transvaginal gamete (GIFT) or zygote intrafallopian transfer (ZIFT): our experience in a total of 1128 treatment cycles.

Authors:  J Tzafettas; A Loufopoulos; A Stephanatos; A Mukherjee
Journal:  J Assist Reprod Genet       Date:  1994-07       Impact factor: 3.412

View more
  9 in total

1.  Association of ethnicity with involuntary childlessness and perceived reasons for infertility: baseline data from the Study of Women's Health Across the Nation (SWAN).

Authors:  Anatte Karmon; Susan M Hailpern; Genevieve Neal-Perry; Robin R Green; Nanette Santoro; Alex J Polotsky
Journal:  Fertil Steril       Date:  2011-09-28       Impact factor: 7.329

2.  Peer-supported learning.

Authors:  P Sackin; M Barnett; A Eastaugh; P Paxton
Journal:  Br J Gen Pract       Date:  1997-02       Impact factor: 5.386

3.  Inhibition of neddylation causes meiotic arrest in mouse oocyte.

Authors:  Mo Yang; Yimei Jin; Siying Fan; Xiaoling Liang; Jialin Jia; Zhongzhou Tan; Tao Huang; Yuan Li; Teng Ma; Mo Li
Journal:  Cell Cycle       Date:  2019-05-21       Impact factor: 4.534

4.  Reassured or fobbed off? Perspectives on infertility consultations in primary care: a qualitative study.

Authors:  Lisa Hinton; Jenny J Kurinczuk; Sue Ziebland
Journal:  Br J Gen Pract       Date:  2012-06       Impact factor: 5.386

5.  Patient and professional views of open access hysterosalpingography for the initial management of infertility in primary care.

Authors:  Scott Wilkes; Greg Rubin; Ann Crosland; Nicola Hall; Alison Murdoch
Journal:  Br J Gen Pract       Date:  2009-05       Impact factor: 5.386

6.  The combination of pronuclear and blastocyst morphology: a strong prognostic tool for implantation potential.

Authors:  Daniela Paes Almeida Ferreira Braga; Amanda S Setti; Rita de Cássia S Figueira; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2013-08-11       Impact factor: 3.412

7.  Who is the gate keeper for treatment in a fertility clinic in Germany? -baseline results of a prospective cohort study (PinK study).

Authors:  Eva Münster; Stephan Letzel; Jasmin Passet-Wittig; Norbert F Schneider; Bettina Schuhrke; Rudolf Seufert; Ulrike Zier
Journal:  BMC Pregnancy Childbirth       Date:  2018-03-05       Impact factor: 3.007

8.  Patient experiences of conservative treatment for early stage endometrial cancer and endometrial hyperplasia with atypia using levonorgestrel intrauterine device: A qualitative study.

Authors:  Montana O'Hara; Monika Janda; Alexandra L McCarthy; James Nicklin; Graeme Walker; Andreas Obermair
Journal:  Gynecol Oncol Rep       Date:  2021-12-22

9.  Effects of Chronic Musculoskeletal Pain on Fertility Potential in Lean and Overweight Male Patients.

Authors:  Fereshteh Dardmeh; Hiva Alipour; Hans Ingolf Nielsen; Sten Rasmussen; Parisa Gazerani
Journal:  Pain Res Manag       Date:  2017-12-24       Impact factor: 3.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.